Trial Compares PET/CT vs Ultrasound for Chronic Low Back Pain Management
This trial investigates the efficacy of F-18 Sodium Fluoride PET/CT guided injections versus ultrasound guided injections for chronic low back pain.
Phase III
Pain Management / Chronic Low Back Pain
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The trial's outcomes could significantly influence treatment protocols for chronic low back pain, potentially favoring advanced imaging techniques. This shift may alter competitive dynamics in the pain management market, necessitating close observation of the trial results.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results for pain reduction and functional improvement metrics, as well as any changes in clinical practice guidelines.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.